Skip to content
Home › 13F recaps › Q3 2026 › CRL

Which funds bought or sold CRL in Q3 2026?

Charles Riv Labs Intl Inc. 3 funds bought, 6 sold, out of 109 tracked funds that have filed for Q3 2026. Among active managers, the estimated net flow was −$561M.

Holdings as of Sep 30, 2026 (Q3 2026)13F deadline Nov 16, 2026 (45 days after quarter end)

PostLinkedIn
Who bought and who sold CRL, by estimated dollars
◀ SoldBought ▶

Top 10 each side. NEW = opened a position, OUT = sold the whole position.

Bought (3)

FundChangeEst. $Now
Fidelity
Asset manager
Added+40.9%+$511M$1.8B
Arrowstreet
Quant & multi-strategy
Added+214.8%+$177M$259M
Bridgewater
Hedge fund
New+$21M$21M

Sold (6)

FundChangeEst. $Now
Invesco
Asset manager
Trimmed-37.9%−$334M$547M
Wellington
Asset manager
Trimmed-82.5%−$314M$67M
Oakmark
Value investor
Trimmed-37.1%−$245M$416M
Citadel
Quant & multi-strategy
Trimmed-57.9%−$204M$148M
Ameriprise
Asset manager
Trimmed-51.1%−$133M$127M
AllianceBernstein
Asset manager
Trimmed-60.9%−$67M$43M

Source: SEC EDGAR Form 13F-HR for each fund, holdings as of Sep 30, 2026. Shares only (options excluded). Estimated $ = change in shares × quarter-end price. Funds may have traded since. Methodology. Not investment advice.

Most bought in Q3 2026 → · Most sold →

Weekly digest · free

13F filings and guru moves, in one short email

A Sunday digest of what famous investors said and filed this week, plus an alert when someone changes stance. Free, no spam, unsubscribe anytime.